year 10, Issue 5 (November - December 2016)                   Iran J Med Microbiol 2016, 10(5): 67-73 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mansouri F, Vaziri S, Janbakhsh A, Sayad B, Najafi F, Karimivafa S M, et al . The effect of Zinc on the Immune responses of pneumococcal vaccination in elderly. Iran J Med Microbiol. 2016; 10 (5) :67-73
1- Department of of Infection disease, Kermanshah University of Medical Sciences, Kermanshah, Iran ,
2- Department of of Infection disease, Kermanshah University of Medical Sciences, Kermanshah, Iran
3- Department of Biostatistics and Epidemiology, School of Public Health, Kermanshah University of Medical Sciences, Kermanshah, Iran
4- Department of Medical Microbiology, School of Public Health, Kermanshah University of Medical Sciences, Kermanshah, Iran
Abstract:   (8208 Views)

Background and Aim: Considering the zinc sulfate as an  immunumedolator in antibody production, the aim of this study was to investigate the effect of zinc sulfate on the immunological response  of pneumococcal vaccines in elderly people over 65.

Materials and Methods: In this case-control study in 2012, 120 patients (over 65 years old) were selected and randomly divided into two separate equal study and control groups. Pneumococcal vaccine injected with the dose of 23 ppv to study and control group then zinc sulfate supplement capsule taken by the study group and a sugar capsule as a placebo by control group for one month period as well. Blood samples were taken before and one month after vaccination, specific antibody (Ab) level against pneumococcal polysaccharide capsule, was measured with Maxisorb ELISA kit. Then findings interpreted with Stata software version 8 (sas ver 8, USA), a t-test was done for assessment of the relationship between independent variables. The effect of zinc, age, smoking and BMI has been assessed on the level of Ab production with regression interpreter.

Results and Conclusions: The average increase in antibody levels before and one month after vaccination in the control group, 42.87 ± 25.21 to 118.87 ± 29 and in the study group were from 41.76 ± 27.51 to 117.66 ± 32.53 units per mL. Zinc, age, sex, BMI and smoking with 95% reliability had no effect on antibody production in both groups. subscription of zinc sulfate for one month period as an immunomodulator after pneumococcal vaccination has no significant effect on the level of antibody production in response to pneumococcal 23 valent vaccines.

Full-Text [PDF 429 kb]   (2219 Downloads)    
Type of Study: Brief Original Article | Subject: Medical Bacteriology
Received: 2016/08/24 | Accepted: 2016/12/8 | ePublished: 2016/12/19

1. Urwin G, Yuan MF, Hall LM, Brown K, Efstratiou A, Feldman RA. Pneumococcal meningitis in the North East Thames Region UK: epidemiology and molecular analysis of isolates. Epidemiol Infect. 1996;117(1):95-102. [PubMed]
2. Butler JC, Hofmann J, Cetron MS, Elliott JA, Facklam RR, Breiman RF. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J Infect Dis. 1996;174(5):986-93. [PubMed]
3. Spindler C, Hedlund J, Jasir A, Normark BH, Ortqvist A. Effects of a large-scale introduction of the pneumococcal polysaccharide vaccine among elderly persons in Stockholm, Sweden. Vaccine. 2008;26(43):5541-6. [PubMed]
4. Bogden JD, Oleske JM, Lavenhar MA, Munves EM, Kemp FW, Bruening KS, et al. Effects of one year of supplementation with zinc and other micronutrients on cellular immunity in the elderly. J Am Coll Nutr. 1990;9(3):214-25. [PubMed]
5. Fraker PJ, King LE, Laakko T, Vollmer TL. The dynamic link between the integrity of the immune system and zinc status. J Nutr. 2000;130(5S Suppl):1399S-406S. [PubMed]
6. Deloria-Knoll M, Steinhoff M, Semba RD, Nelson K, Vlahov D, Meinert CL. Effect of zinc and vitamin A supplementation on antibody responses to a pneumococcal conjugate vaccine in HIV-positive injection drug users: a randomized trial. Vaccine. 2006;24(10):1670-9.
7. Artz AS, Ershler WB, Longo DL. Pneumococcal vaccination and revaccination of older adults. Clin Microbiol Rev . 2003;16(2):308-18. [PubMed]
8. Concepcion NF, Frasch CE. Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol. 2001;8(2):266-72. [PubMed]
9. Rubins JB, Alter M, Loch J, Janoff EN. Determination of antibody responses of elderly adults to all 23 capsular polysaccharides after pneumococcal vaccination. Infect Immun. 1999; 67(11):5979-84.
10. Kumar R, Burns EA. Age-related decline in immunity: implications for vaccine responsiveness. Expert review of vaccines. 2008;7(4):467-79. [PubMed]
11. Ikeda S, Saito H, Fukatsu K, Inoue T, Han I, Furukawa S, et al. Dietary restriction impairs neutrophil exudation by reducing CD11b/CD18 expression and chemokine production. Arch Surg. 2001, 136(3):297-304. [PubMed]
12. Mufson MA, Krause HE, Schiffman G, Hughey DF. Pneumococcal antibody levels one decade after immunization of healthy adults. Am J Med Sci. 1987; 293(5):279-84. [PubMed]
13. Musher DM, Groover JE, Rowland JM, Watson DA, Struewing JB, Baughn RE, et al. Antibody to capsular polysaccharides of Streptococcus pneumoniae: prevalence, persistence, and response to revaccination. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 1993; 17(1):66-73.
14. Hilleman MR, Carlson AJ, Jr., McLean AA, Vella PP, Weibel RE, Woodhour AF. Streptococcus pneumoniae polysaccharide vaccine: age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines. Reviews of infectious diseases. 1981; 3 Suppl:S31-42. [PubMed]
15. Vella PP, McLean AA, Woodhour AF, Weibel RE, Hilleman MR. Persistence of Pneumococcal antibodies in human subjects following vaccination. Proceedings of the Society for Experimental Biology and Medicine Society for Experimental Biology and Medicine. 1980; 164(4):435-8. [Article]
16. Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. Jama. 1993; 270(15):1826-31. [PubMed]
17. Sankilampi U, Honkanen PO, Pyhala R, Leinonen M. Associations of prevaccination antibody levels with adverse reactions to pneumococcal and influenza vaccines administered simultaneously in the elderly. Vaccine. 1997; 15(10):1133-7.
18. Barbour EK, Hamadeh SK, Bejjani NE, Faroon OM, Eid A, Sakr W, et al. Immunopotentiation of a developed Salmonella enterica serotype enteritidis vaccine by thymulin and zinc in meat chicken breeders. Vet Res Commun. 2001; 25(6):437-47. [PubMed]
19. Provinciali M, Montenovo A, Di Stefano G, Colombo M, Daghetta L, Cairati M, et al. Effect of zinc or zinc plus arginine supplementation on antibody titre and lymphocyte subsets after influenza vaccination in elderly subjects: a randomized controlled trial. Age Ageing. 1998; 27(6):715-22. [PubMed]
20. Seferian PG, Martinez ML. Immune stimulating activity of two new chitosan containing adjuvant formulations. Vaccine. 2000; 19(6):661-8. [Article]
21. Duchateau J, Delepesse G, Vrijens R, Collet H. Beneficial effects of oral zinc supplementation on the immune response of old people. Am J Med. 1981; 70(5):1001-4. [PubMed]
22. Girodon F, Galan P, Monget AL, Boutron-Ruault MC, Brunet-Lecomte P, Preziosi P, et al. Impact of trace elements and vitamin supplementation on immunity and infections in institutionalized elderly patients: a randomized controlled trial. MIN. VIT. AOX. geriatric network. Arch Intern Med. 1999; 159(7):748-54. [PubMed]
23. Prasad AS. Effects of zinc deficiency on Th1 and Th2 cytokine shifts. J Infect Dis. 2000; 182 Suppl 1:S62-8. [PubMed]
24. Meydani SN, Barnett JB, Dallal GE, Fine BC, Jacques PF, Leka LS, et al. Serum zinc and pneumonia in nursing home elderly. Am J Clin Nutr. 2007; 86(4):1167-73. [PubMed]
25. Mohan L. Sopori WK. Immunomodulatory effects of cigarette smoke. J Neuroimmunol. 1998; 83:148-56. [PubMed]
26. Ament A, Baltussen R, Duru G, Rigaud-Bully C, de Graeve D, Ortqvist A, et al. Cost-effectiveness of pneumococcal vaccination of older people: a study in 5 western European countries. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2000; 31(2):444-50. [Article]
27. Butler JC, Shapiro ED, Carlone GM. Pneumococcal vaccines: history, current status, and future directions. Am J Med. 1999; 107(1A):69S-76S. [PubMed]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Iranian Journal of Medical Microbiology

Designed & Developed by : Yektaweb | Publisher: Farname Inc